Tartrazine-containing drugs.
Pharmaceutical manufacturers producing or distributing drugs in Canada were surveyed between December 1974 and March 1975 to determine which of their products contained tartrazine, a pyrazole aniline dye. A list of some 580 drug products of the 156 manufacturers who responded is presented for aid in managing the tartrazine-sensitive patients.
D000814:Aniline Compounds / Q000009:adverse effects; D004396:Coloring Agents / Q000009:adverse effects; D004342:Drug Hypersensitivity / Q000517:prevention & control*; D006801:Humans; D011720:Pyrazoles / Q000009:adverse effects; D013678:Technology, Pharmaceutical
D000814:Aniline Compounds; D004396:Coloring Agents; D011720:Pyrazoles